Beta-blocker use and the changing epidemiology of out-of-hospital cardiac arrest rhythms

Resuscitation

Volumn 76, Issue 3, 2008, Pages 376-380

  Youngquist, Scott T ^a,b   Kaji, Amy H ^a,b   Niemann, James T ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Beta blockers; Cardiac arrest; Pulseless electrical activity; Ventricular fibrillation

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ADULT; ARTICLE; ASYSTOLE; CIRCULATION; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE CLASSIFICATION; DRUG USE; ETHNICITY; FEMALE; HEART ARREST; HEART RHYTHM; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANTEL HAENSZEL TEST; MEDICAL ERROR; MEDICAL RECORD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; COHORT STUDIES; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; FEMALE; HEART ARREST; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VENTRICULAR FIBRILLATION;

EID: 38849207734     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2007.08.022     Document Type: Article

References (25)

1. Kette F. Increased survival despite a reduction in out-of-hospital ventricular fibrillation in north-east Italy. Resuscitation 72 (2007) 52-58
2. Polentini M.S., Pirrallo R.G., and McGill W. The changing incidence of ventricular fibrillation in Milwaukee, Wisconsin (1992-2002). Prehosp Emerg Care 10 (2006) 52-60
3. Bunch T.J., White R.D., Friedman P.A., Kotke T.E., Wu L.A., and Packer D.L. Trends in treated ventricular fibrillation out-of-hospital cardiac arrest: a 17-year population-based study. Heart Rhythm 1 (2004) 255-259
4. Hess E.P., Campbell R.L., and White R.D. Epidemiology, trends, and outcome of out-of-hospital cardiac arrest of non-cardiac origin. Resuscitation 72 (2007) 200-206
5. Stafford R.S., Monti V., Furberg C.D., and Ma J. Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States. Hypertension 48 (2006) 196-197
6. Bradley E.H., Herrin J., Mattera J.A., et al. Quality improvement efforts and hospital performance: rates of beta-blocker prescription after acute myocardial infarction. Med Care 43 (2005) 282-292
7. Exner D.V., Reiffel J.A., Epstein A.E., et al. Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the antiarrhythmics versus implantable defibrillators (AVID) trial. J Am Coll Cardiol 34 (1999) 325-333
8. Connolly S.J., Dorian P., Roberts R.S., et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial. JAMA 295 (2006) 165-171
9. http://sph.bu.edu/images/stories/scfiles/epidemiology/senstoolv1.01.xls, accessed on March 15, 2007.
10. Fox M.P., Lash T.L., and Greenland S. A method to automate probabilistic sensitivity analysis of misclassified binary variables. Int J Epidemiol 34 (2005) 1370-1376
11. Greenland S., and Gustafson P. Accounting for independent nondifferential misclassification does not increase certainty that an observed association is in the correct direction. Am J Epidemiol 164 (2006) 63-68
12. Herlitz J., Engdahl J., Svensson L., et al. Changes in demographic factors and mortality after out-of-hospital cardiac arrest in Sweden. Coron Artery Dis 16 (2005) 51-57
13. Herlitz J., Eek M., Engdahl J., et al. Factors at resuscitation and outcome among patients suffering from out of hospital cardiac arrest in relation to age. Resuscitation 58 (2003) 309-317
14. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol 48 (2006) e247-e346
15. Freemantle N., Cleland J., Young P., Mason J., and Harrison J. β-Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 318 (1999) 1730-1737
16. Bonet S., Agusti A., Arnau J.M., et al. Beta-adrenergic blocking agents in heart failure-benefits of vasodilating and non-vasodilating agents according to patients' characteristics: a meta-analysis of clinical trials. Arch Intern Med 160 (2000) 621-627
17. Foody J.M., Farrell M.H., and Krumholz H.M. β-Blocker therapy in heart failure. Scientific review. JAMA 287 (2002) 883-889
18. Aupetit J.F., Frassati D., Biu-Xuan B., Freysz M., Faucon G., and Timour Q. Efficacy of a β-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia duration. Cardiovasc Res 37 (1998) 656-755
19. Coetzee A., and Coetzee G. β-adrenergic blockade during severe ischemia. J Cardiothorac Vasc Anesth 16 (2002) 670-678
20. Reiter M.J. Cardiovascular drug class specificity: β-blockers. Prog Cardiovasc Dis 47 (2004) 11-33
21. Menegazzi J.J., Davis E.A., Yealy D.M., et al. An experimental algorithm versus standard advanced cardiac life support in a swine model of out-of-hospital cardiac arrest. Ann Emerg Med 22 (1993) 235-239
22. Killingsworth C.R., Wei C.C., Dell'Italia L.J., et al. Short-acting beta-adrenergic antagonist esmolol given at reperfusion improves survival after prolonged ventricular fibrillation. Circulation 109 (2004) 2469-2474
23. Huang L., Weil M.H., Cammarata G., Sun S., and Tang W. Non-selective β-blocking agent improves the outcome of cardiopulmonary resuscitation in a rat model. Crit Care Med 32 Suppl (2004) S378-S380
24. 1-Adrenergic blockade during cardiopulmonary resuscitation improves survival. Crit Care Med 32 Suppl (2004) S440-S443
25. Cao L., Weil M.H., Sun S., and Tang W. Vasopressor agents for cardiopulmonary resuscitation. J Cardiovasc Pharmacol Ther 8 (2003) 115-121